CellCept (Cardinal Health)
Welcome to the PulseAid listing for the CellCept drug offered from Cardinal Health. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | Mycophenolate mofetil |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1995-05-03 |
END MARKETING DATE: | 0000-00-00 |
CellCept HUMAN PRESCRIPTION DRUG Details:
Item Description | CellCept from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1995-05-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55154-3122_725e4073-32f8-4d85-afd4-0c7c7d77874e |
PRODUCT NDC: | 55154-3122 |
APPLICATION NUMBER: | NDA050722 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers: